Alaunos Therapeutics, Inc. (TCRT) Reports In-Line Q2 EPS

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q2 EPS of ($0.05), in-line with the analyst estimate of ($0.05).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49